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Introduction: This research project sets out to design an integrated disease management model 
for patients with COPD who were referred to a secondary care setting and who qualified for 
pharmacological and nonpharmacological intervention options.
Theory and methods: The integrated disease management model was designed according 
to the guidelines of the European Pathway Association and the content founded on the Chronic 
Care Model, principles of integrated disease management, and knowledge of quality manage-
ment systems.
Results: An integrated disease management model was created, and comprises 1) a diagnostic tra-
jectory in a secondary care setting, 2) a nonmedical intervention program in a primary care setting, 
and 3) a pulmonary rehabilitation service in a tertiary care setting. The model also includes a quality 
management system and regional agreements about exacerbation management and palliative care.
Discussion: In the next phase of the project, the COPDnet model will be implemented in at least 
two different regions, in order to assess the added value of the entire model and its components, 
in terms of feasibility, health status benefits, and costs of care.
Conclusion: Based on scientific theories and models, a new integrated disease management 
model was developed for COPD patients, named COPDnet. Once the model is stable, it will 
be evaluated for its feasibility, health status benefits, and costs.
Keywords: COPD, COPD management, integrated care, Chronic Care Model, health status
Introduction
COPD is a highly prevalent disease and often puts a high burden of disease on those 
affected, even when they are in a relatively stable phase of their disease or only have 
mild-to-moderate airway obstruction.1 Moreover, the impact of COPD places an inor-
dinate burden on health care resources given the significant direct and indirect costs 
of care.2 Projections on the future suggest a further rise in the prevalence of COPD 
patients, especially of patients with severe or very severe disease.3
Given this high prevalence, the expected rise, and the significant impact on the 
individual and on society, it is important to establish a care process that maximizes 
outcomes in relation to the efforts and costs made.4
Surprisingly, little scientific data are available on the outcome of “real-life” care in 
these patients in the chronic phase of their illness, that is to say, outcomes of care outside 
the remit of treatment of exacerbations.5 The first publications on the outcomes of real-life 
chronic care in COPD are available and suggest room for improvement for the organiza-
tion of care, as well as for the content of care and the cost-effectiveness of care.6–9
Better outcomes of care for patients with chronic conditions, such as type 2 dia-
betes, are to be expected from the widespread use of integrated disease management 
programs.10 This also counts for patients with COPD.11 According to the definition of 
integrated disease management by Peytremann-Bridevaux and Burnand,12 such pro-
grams should address simultaneously both the content of care and the organization of 
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care, that is to say, to provide 1) a patient-centered, holistic 
care based on the patient’s individual needs, captured through 
a thorough assessment in 2) a synchronized manner with the 
coordination of services and therapies across health care set-
tings and health care providers.13
The most recent systematic review confirmed the evidence 
for the efficacy of integrated disease management interven-
tions in people with COPD of at least 3 months duration on 
disease-specific quality of life and exercise tolerance up to 
12 months of follow-up and demonstrated a reduction in 
respiratory-related hospital admissions and hospital days per 
person.14 However, when taking a closer look at the studies, 
it appeared that only five of the 26 included studies described 
an integrated disease management program within a com-
bination of primary and secondary health care settings.15–19 
In addition, interventions were directed toward either the 
content of care15,16,19 or the organization of care17,18 but never 
addressed them together. A recent publication on the effects 
of the German disease management program for COPD, 
predominantly directed at primary care, also lends support to 
the effectiveness of an integrated approach for COPD.20
Finally, our impression is that integrated care models 
are, as yet, only in limited use in our present care delivery 
pathways. This was confirmed in a recently performed survey 
in five European Union countries, including the Netherlands. 
In this article, the authors concluded that COPD health care 
pathways are fragmented and care is not integrated properly. 
In order to succeed in providing integrated chronic disease 
management care, knowledge from controlled studies should 
be translated into practical applications.21
This article describes the results of a research project, which 
was set out to design an integrated disease management model 
for patients with COPD, named the COPDnet integrated care 
model. This model may serve as a blueprint for the establish-
ment of regular care for COPD patients across all health care 
settings, and it will address both the content and the organiza-
tional aspects of care. The COPDnet integrated care model was 
specifically designed for patients with moderate or severe bur-
den of disease, who, according to the Dutch Standard of Care 
for COPD, meet the criteria for care in a primary, secondary, 
or tertiary care setting and qualify for both pharmacological 
and nonpharmacological intervention options.22
Description of the care practice
Description of the development process
The COPDnet integrated care model was designed accord-
ing to the guidelines of the European Pathway Association 
(EPA) in which the following seven phases are distinguished: 
1) a screening phase, 2) a project management phase, 3) a 
diagnostic phase (baseline measurements, mapping existing 
pathways), 4) a design and plan phase (development of care 
pathway), 5) an implementation phase, 6) an evaluation 
phase, and 7) a continuous follow-up phase (making it clini-
cal routine and ongoing review).23 We designed this model 
because it seemed particularly applicable to in-hospital, pri-
mary care, and cross-boundary projects. In Phase II and III, an 
analysis and baseline measurements were carried out and we 
found that the process of care at that time did not sufficiently 
comply with the principles of integrated disease management 
care. During the course of Phase IV, the designing process, 
general practitioners (GPs), respiratory nurses, pulmonolo-
gists, representatives of the Dutch Lung Foundation, and 
medical advisors of health insurance companies externally 
reviewed the COPDnet integrated care model.
The content of the COPDnet model
The definition of chronic disease management was used as a 
starting point for the development of the COPDnet integrated 
care model.12 In order to operationalize this definition in the 
designing process, we have used the Chronic Care Model 
(CCM) as a guideline.24 The CCM sets out to transform 
the daily care for patients with chronic illnesses from acute 
and reactive to proactive, planned, and population based.25 
Moreover, application of the principles of the CCM in the 
context of COPD has shown added value and highlighted 
the need for implementing multiple components of the CCM 
to prevent complications and improve outcomes in patients 
with COPD.26 Therefore, the following four elements of the 
health care system, as identified in the CCM, were used in our 
COPDnet integrated care model: 1) self-management support, 
2) decision support, 3) delivery system design, and 4) clini-
cal information systems. The CCM is not an explanatory 
theory, yet the model is more like a flexible evidence-based 
guideline.27 We have added specific diagnostic procedures 
to our model in order to better address the complexity and 
heterogeneity of COPD and thereby to provide the best per-
sonalized treatment of a given patient.28
Figure 1 represents a graphical overview of all the ele-
ments of the COPDnet integrated care model, that is, 1) a 
diagnostic trajectory carried out in a secondary care set-
ting, 2) a nonmedical intervention program in a primary 
care setting, and 3) a pulmonary rehabilitation service in 
a tertiary care setting. The model also includes a Quality 
Management System (QMS) and a set of regional network 
agreements about exacerbation management and palliative 
care. The COPDnet model uses the diagnostic trajectory of 
which one of the authors (AJvtH) was cocreator and is based 
on the Delphi Panel Study.29 Novelties in this diagnostic 
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trajectory are a measurement of dynamic hyperinflation, an 
objectivation of physical activity measured with the DynaPort 
MoveMonitor (McRoberts, The Hague, the Netherlands), and 
a systematic evaluation of the burden of disease measured 
with the Nijmegen Clinical Screening Instrument (NCSI). 
The identification of comorbidities is explicitly part of the 
diagnostic workup in the COPDnet model and is acted upon if 
and when this is deemed appropriate by the pulmonologist.30 
Details regarding the content of the diagnostic trajectory are 
published elsewhere.31
We describe how the four CCM components have been 
integrated in the COPDnet model in detail below.
self-management support
More and more, the reinforcement of self-management skills 
is found to be an important aspect in the care of patients with 
a chronic health condition. An effective self-management 
strategy should include the initiation of behavioral change, 
be tailored individually, take the patient’s perspective into 
account, and be adapted to the course of the patient’s dis-
ease and comorbidities.32 Recently, international consensus 
has been reached regarding a conceptual definition of what 
a COPD self-management intervention should comprise.33 
Subsequently, we have included the following strategies 
for self-management support in our COPDnet model: 1) 
Patient Activation Measurement (PAM) and Motivational 
Interviewing, 2) Capabilities Opportunities Motivation-
Behavior (COM-B) model, 3) shared decision making, and 
4) an individual care plan.
PaM and Motivational Interviewing
An understanding of the level of activation for self-
management, defined as “patients’ knowledge, skills, and 
self-efficacy regarding self-management” is important 
because it gives clues as to how self-management may be 
improved by the individual patient.34 The level of activation 
for self-management can be determined with the PAM.34,35 
In the COPDnet integrated care model, we use the shortened 
13-item version of the PAM.34 This measures patients’ activa-
tion levels for self-management and classifies patients into the 
following four different levels: 1) believing in the importance 
of their own role, 2) having the confidence and knowledge 
required to take action, 3) actually taking action to maintain 
and improve health, and 4) staying the course even under 
stress. With the outcome of the PAM, the stages of change in 
health behavior can be monitored.36 Based on these outcomes, 
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Figure 1 The COPDnet integrated care model.
Abbreviations: DT, diagnostic trajectory; gP, general practitioner; PrOMs, Patient-reported Outcome Measurements.
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health care professionals apply motivational interviewing 
techniques to improve patients’ self-management skills. 
Motivational interviewing is a communication technique, 
which focuses on helping patients to change their behaviors, 
by exploring their personal perspectives as well as their 
perceived barriers.37
COM-B model
The COM-B model is a theoretical model, which suggests 
that there are three ways in which human behavior (B) results 
from the interaction between: psychological capabilities (C), 
social and environmental opportunities (O), and motivation 
(M). This model helps to identify which dimension in this 
COM-B model should be addressed to encourage behavioral 
change in patients.38
shared decision making
Shared decision making is used in our COPDnet model. 
Although the principles of shared decision making are 
well documented, we have described a comprehensive 
practical approach to patient-centered care. Achieving 
shared decision making relies on a good relationship in the 
clinical encounter so that information is shared and patients 
are supported to deliberate and express their preferences 
and views during the decision-making process.39 Shared 
decision making is based on introducing a choice (choice 
talk), describing options (option talk), and helping patients 
to explore preferences and to make informed decisions 
(decision talk).39 In our COPDnet model, the choice talk 
takes place during day 1, the option talk takes place during 
day 2, and the decision talk takes place during day 3 of the 
diagnostic trajectory.
Individual care plan
Based on the various talks between the health care profes-
sionals and the patient, the patient is asked to construct 
an individual care plan – including the patient’s personal 
objective(s) – between visits 2 and 3. During visit 3, this 
individual care plan will be further explored with the respira-
tory nurse and developed into informed preferences regarding 
treatment options.
Decision support
guidelines on decision making
Based on state-of-the-art insights, practical guidelines on 
decision making were introduced in our model for 1) addi-
tional diagnostics, 2) classification of the burden of disease, 
and 3) choices between care settings for personalized 
interventions.
additional diagnostic tests
The COPDnet diagnostic trajectory is designed to provide 
an optimal diagnosis with minimal measurements, as ade-
quately as possible. The model creates an overview of the 
individual traits of each patient. In some patients, a further 
understanding of the pathophysiology is necessary in order 
to come to a proper diagnosis or to set an appropriate indica-
tion for the best interventions. For these patients, additional 
diagnostics may be required after day 1 of the diagnostic 
trajectory. In patients to whom exercise training is offered 
as intervention, a cardiopulmonary exercise test is carried 
out. The performance on a maximal exercise test is used to 
set individual training parameters.40 Further diagnostic tests 
may be requested (Table 1).
Table 1 additional diagnostics
Additional diagnostics Aim Indication
Measurement of static lung 
volumes
To determine the presence of restrictive 
pulmonary function impairment
– FVC ,80% of the predicted value
CO diffusion capacity To determine whether or not CO 
diffusion is limited
– Persisting doubts about the diagnosis of asthma or COPD
– suspected IlD
– Discrepancy between spirometric values and desaturation 
during the 6MWD
histamine provocation test To determine the presence and severity 
of bronchial hyperreactivity
– Doubts about the diagnosis of asthma or COPD
– To set up or adjust medication in case of asthma
Cardiopulmonary exercise test To determine maximal exercise capacity 
and cause of exercise limitation
– steps per day ,5,000 or VMU ,0.210 and 6MWD ,70% 
of predicted value and the patient is willing to participate 
in an exercise training program
CT thorax Imaging of the thorax – Doubts about the presence of malignancy or IlD
referral to cardiologist or enT 
specialist
To determine the diagnosis and 
treatment of relevant comorbidity
– suspicion of relevant cardiac or enT comorbidity
Abbreviations: 6MWD, 6-minute walk distance; CO, carbon monoxide; CT, computed tomography; enT, ear nose throat; FVC, forced vital capacity; IlD, interstitial lung 
disease; VMU, vector magnitude units.
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Classification of burden of disease
The diagnostic trajectory of the COPDnet model aims to 
provide a classification of the burden of disease on the patient. 
Subsequently, this classification is used for the allocation of 
patients to the appropriate care setting, which means either a 
referral back to a primary care setting or a referral to a tertiary 
care setting for a pulmonary rehabilitation assessment.
Whereas the severity of COPD is defined by the 
pathophysiological impairment (airway obstruction), the 
burden of disease is based on the perceived health problems 
by the individual patient.41 This allows tailoring treatment 
to the patient, based on a comprehensive assessment of the 
individual causes of the burden of disease. The severity 
of the burden of disease is classified into mild, moderate, 
and severe (Table 2). Choices with respect to the indices 
of and cutoff values for the burden of disease in our model 
are partially based on the existing literature and the expert 
opinion based on such thresholds, for instance, to classify 
the 6-minute walk distance.
Choices between care settings for personalized 
interventions
During the diagnostic trajectory in a secondary care setting, 
1) the medical diagnosis is confirmed, 2) classification of the 
burden of disease is made, and 3) the number and complexity 
of individual traits are determined. The classification of the 
burden of disease leads to the next phase, that is, referral to 
a primary, secondary, or tertiary care setting for tailor-made 
interventions. An important aim of the COPDnet model 
is the provision of appropriate care of patients as close as 
possible to their home environment, that is, preferably in a 
primary care setting and, only if necessary, in a secondary 
or tertiary care setting.
In principle, patients with mild or moderate burden 
of disease are (re)referred to a primary care setting and, 
according to their individual care plan, will be offered one 
or more nonmedical intervention module(s) provided by 
allied health care professionals. In order to enable referral of 
the right patients to the appropriate nonmedical intervention 
module(s), a guideline on decision making was developed 
for the allocation of COPD patients to modules provided 
by dieticians, occupational therapists, and physiotherapists 
(Figure 2).
Patients with a severe burden of disease may be referred 
to a pulmonary rehabilitation setting, where an additional 
prerehabilitation assessment is carried out and the indica-
tion for pulmonary rehabilitation is re-established. Again, 
personal goals are set and the components of the rehabilita-
tion program are determined, which means that either an 
inpatient-based rehabilitation program or an outpatient-based 
rehabilitation program is indicated.42
In the case of such an indication, patients continue under 
supervision for some time in a secondary care setting by 
the pulmonologist and/or respiratory nurse. Typically, this 
applies to patients who were not on the appropriate inhalation 
medication yet, as recommended by current guidelines. Also, 
when more time is required to reach an agreement with the 
patient on the individual care plan.
Multilevel outcome measurement
Most importantly, we deliberately set out to include a 
systematic registration of the outcome of care at multiple 
Table 2 Classification of burden of disease
Mild Moderate Severe
– exacerbations: none in the last year – exacerbations: one in the last year – exacerbations: $2 in the last year or one 
hospitalization due to exacerbation COPD
– Comorbidities: none or do not contribute 
to the burden of disease
– Comorbidities: present and contribute 
moderately to the burden of disease
– Comorbidities: present and contribute 
markedly to the burden of disease
– MrC =0–1 – MrC =1–2 – MrC =3–5
– BMI .21 or ,30 – BMI ,21 or 30–35 – BMI ,21 or .35
– 6MWD $500 m – 6MWD =400–500 m – 6MWD ,400 m
– Pal $1.7 – Pal =1.4–1.7 – Pal ,1.4
– CCQ ,2.0 – CCQ =2–3 – CCQ .3.0
– nCsI = normal or mildly disturbed – nCsI = moderately disturbed – nCsI = severely disturbed
– no or mild disturbance of the social 
participation (work, family, hobbies, 
sports, and so on)
– Moderate disturbance of the social 
participation (work, family, hobbies, 
sports, and so on)
– severe disturbance of the social 
participation (work, family, hobbies, 
sports, and so on)
Note: Pal was measured with the MoveMonitor.
Abbreviations: 6MWD, 6-minute walk distance; BMI, body mass index; CCQ, Clinical COPD Questionnaire; MrC, Medical research Council; nCsI, nijmegen Clinical 
screening Instrument; Pal, physical activity level.
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levels in the COPDnet model, using Patient-Reported Out-
come Measurements (PROMs): 1) NCSI, 2) Clinical COPD 
Questionnaire (CCQ), and 3) 13-PAM. Data from the NCSI 
and CCQ are collected on day 1 of the diagnostic trajectory 
and on 6 months follow-up. The outcomes of the 13-PAM 
are also collected on day 1 of the diagnostic trajectory, the 
last day of the diagnostic trajectory (day 2 or 3), and also 
6 months follow-up.
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±7KH1&6,VFRUHV\HOORZRU UHGRQRIWKHVXEGRPDLQV VHYHULW\LPSDFWDFWLYLW\RIWKH GRPDLQG\VSQHD±&$7VFRUH!±&&4VXEGRPDLQV\PSWRPV VFRUH!±037WHVWDIWHUEURQFKRGLODWLRQ DQ,&UHGXFWLRQRI!
•
•
0RGXOH&RQWURO\RXUEUHDWK±K\SHUYHQWLODWLRQ$QDPQHVWLF7KHSUHVHQFHRIFKURQLFK\SHUYHQWLODWLRQDQGWKHUHE\UHODWHGFRPSODLQWV&OLQLPHWULFV±%ORRGJDVS&2N3DSOXV %,&PPRO/±1LMPHJHQK\SHUYHQWLODWLRQ TXHVWLRQQDLUHVFRUH!
•
•
0RGXOH7UDLQ\RXUERG\$QDPQHVWLF/LPLWHGSK\VLFDODFWLYLW\LQGDLO\OLIHLQFRPELQDWLRQZLWKDOLPLWHGH[HUFLVHFDSDFLW\&OLQLPHWULFV±0:'RIWKHSUHGLFWHG YDOXHLQFRPELQDWLRQZLWKWKH QXPEHURIVWHSVSHUGD\ RU3$/
•
•
0RGXOH8QGHUZHLJKWDQGXQZDQWHGZHLJKWORVV$QDPQHVWLF7KHSUHVHQFHRILQYROXQWDU\ZHLJKWORVV&OLQLPHWULFV±%0,±,QYROXQWDU\ZHLJKWORVV! ZLWKLQPRQWKRU! ZLWKLQPRQWKV
•
•
0RGXOH2YHUZHLJKW$QDPQHVWLF7KHSUHVHQFHRILQYROXQWDU\ZHLJKWJDLQ&OLQLPHWULFV±%0,RU%0,\HDUV±:DLVWFLUFXPIHUHQFH FPZRPHQRU FPPHQ
•
•
0RGXOH5HGXFHG))0,&OLQLPHWULFV±%0,±))0,ZRPHQRU PHQ
•
Figure 2 guideline on decision making for nonmedical intervention modules in a primary care setting.
Note: Pal was measured with the MoveMonitor.
Abbreviations: 6MWD, 6-minute walk distance; BIC, blood isotope clearance; BMI, body mass index; CaT, COPD assessment test; CCQ, Clinical COPD Questionnaire; 
FFMI, Fat-Free Mass Index; IC, inspiratory capacity; MPT, manually paced tachypnea; nCsI, nijmegen Clinical screening Instrument; Pal, physical activity level; pCO2, partial 
pressure of carbon dioxide.
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nCsI
The NCSI enables the clinician to obtain a valid, reliable, 
and detailed picture of a patient’s health status by measuring 
multiple sub-domains covering the following four domains: 
physiological functioning, symptoms, functional impairment, 
and quality of life.43 In combination with the automated 
monitoring system of the Patient Profile Chart, the NCSI can 
easily be used in routine care as a guide to patient-tailored 
treatment.43 The Patient Profile Chart offers a visual and, 
therefore, easily interpretable picture of the integral health 
status of an individual patient for the pulmonologist, respira-
tory nurse, and the patient.44
CCQ
The CCQ is a self-administered 10-item questionnaire spe-
cially developed to measure clinical control in patients with 
COPD. Data support the validity, reliability, and responsive-
ness of this questionnaire.45
13-PaM
The 13-PAM is a valid and reliable 13-item Guttman-like scale 
and assesses the level of activation for self-management.34,35
Delivery system design
Cohesive, transmural model
The COPDnet model also aims to improve the transmural, 
organizational aspects of care. In order to do this, we opera-
tionalized the following in our model: 1) standardization of 
(electronic) referral procedures for the GP to a secondary care 
setting, 2) proactive management of the patient’s expecta-
tions by the GP, 3) preparation of patients for the setting of 
goals after the diagnostic trajectory (information provided by 
an information flyer), 4) standardization of reporting by the 
pulmonologist and respiratory nurse, and 5) agreements as to 
what information is provided to allied health care providers 
when referring a patient for an intervention module.
Finally, every 3 months, consultation takes place between 
representatives of health care providers from primary and 
secondary care settings and between representatives of 
secondary care and the regional tertiary care rehabilitation 
center to discuss organizational aspects of care.
QMs
Based on the knowledge of quality management models, and 
in collaboration with the participating health care profession-
als, we developed a QMS primarily focused on the diagnostic 
trajectory in secondary care settings. The QMS aims to 
provide a continuous quality improvement for pulmonary 
specialists and respiratory nurse specialists participating in 
the COPDnet integrated care model, by giving systematic 
feedback on outcomes of care based on PROMs. The COP-
Dnet QMS includes 1) case presentation and discussion, 
2) audit, and 3) education and training.
Case presentation and discussion
Every 3 months, one to two case histories are presented by 
the pulmonologist and respiratory nurse and then discussed 
with a psychologist and an independent chairman.46 Discus-
sions may cover the interpretation of health status measure-
ments, interviewing techniques, decisions on additional 
diagnostic tests and classification of the burden of disease, 
or choices with regard to the individual care plan. Mirroring 
the COPDnet guidelines, decision making is an important 
element in this process.
audit
Audits are regularly performed between health care profes-
sionals from different hospitals working with the COPDnet 
model to evaluate and to discuss the aspects of the organiza-
tion of the care process.47 Sharing experiences between users 
are thought to be helpful to further optimize the model.
education and training
Education and training sessions are offered depending on the 
specific needs indicated by the health care professionals. The 
topics of the education and training may vary, but they are 
always related to the COPDnet model.
exacerbation management and palliative care
In the COPDnet model, regional action plans with regard to 
exacerbation management and palliative care were agreed.48,49
Clinical information systems
electronic health record (ehr)
An EHR is used to register key administrative and clinical 
data of patients during the diagnostic trajectory of the COPD-
net model. Relevant clinical parameters for the evaluation of 
the individual health status at baseline, as well as the change 
of health status over time, systematically registered in the 
EHR. The data may be used to support the clinical decision-
making process at the individual level and may also be used 
in aggregated (anonymized) data at the population level for 
quality purposes, as well as for scientific research purposes. 
Also, important features with regard to the care process are 
periodically analyzed.
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electronic communication platform
To facilitate digital communication between health care pro-
fessionals and the patient in the COPDnet model, a patient 
portal is used, for instance, to exchange information or to 
enable the administration of questionnaires at home at regu-
lar intervals. This portal is considered an important digital 
add-on contributing to the effectiveness of the care model 
but also to the perceived quality of care by patients.
Discussion
With the current project, we wish to present an evidence-
based comprehensive integrated disease management model 
for patients with COPD with moderate or severe burden of 
disease, who, according to the Dutch Standards of Care for 
COPD, meet the criteria for shared care between primary 
and secondary care settings.22
The idea behind this project arose from the awareness of 
the poor and fragmented use of the principles of integrated 
care in COPD patients in real-life care in various health care 
settings.21 This is not in keeping with the scientific evidence 
of the added value of an integrated approach, in terms of 
improving the quality and the efficiency of care and reducing 
health care costs.50 In addition, the first observational studies 
on the outcome of real-life COPD care, recently carried out in 
Germany, demonstrated extensive room for improvement.6–9 
More studies on the outcome of real-life COPD care are 
expected in due time.51–53 Last but not least, the poor outcome 
observations are in line with a recently performed survey in 
five European Union countries, including the Netherlands, in 
which the authors concluded that COPD health care pathways 
are fragmented and care is not integrated properly.21
We assume that the availability of a scientifically docu-
mented care pathway, based on principles of integrated dis-
ease management and founded on the CCM, may facilitate the 
wider use of the principles of integrated disease management 
care in real-life clinical practice and that it will boost the 
clinical effectiveness of care in COPD patients. Evidence 
in support or this assumption is the outcome of a study on 
the effects of the introduction of a QMS-targeting patients 
treated on an outpatient base in hospitals in Denmark. In 
this study, it was found that with the implementation of a 
nationwide registration, the care provided was more in line 
with principles of integrated care.53
Although the added value of our model has to be empiri-
cally determined, we believe that it has a strong basis. Dur-
ing the development of our integrated disease management 
pathway, we used a robust and scientifically based method, 
that is, the seven-phase model of the EPA.23 With this method, 
several other care pathways have been successfully devel-
oped and implemented, including a pathway for acutely ill 
patients with COPD who were in need of hospitalization.54–57 
In the seven-phase model, co-creation in the designing 
process is acknowledged to be crucial in establishing a sup-
ported innovative care model.58 Therefore, early on in the 
designing process, we consulted different stakeholders, both 
with respect to their opinions regarding the care process and 
their views on the content of the integrated disease manage-
ment pathway.
Notably, the content of our model addresses disease-
specific aspects based on knowledge regarding its complexity 
and heterogeneity,1 but it also includes features relating to the 
more general needs of patients with a chronic condition. We 
found inspiration for the latter in the CCM.24 The assumption 
of the CCM is that better outcomes of care in patients with 
chronic conditions, such as COPD, are to be expected as a 
result of the productive interaction between proactive health 
care professionals and an activated patient. To enable and 
support this productive interaction, several features of the 
health care system should be reconsidered and improved by 
united efforts. These improvements concern self-management 
strategies, decision support, delivery system design, and 
clinical information systems.26 In our COPDnet model, all 
these four elements are explicitly addressed. With the incor-
poration of the systematic measurement on outcomes (using 
PROMs) of the integrated care pathway, as a basis for the 
QMS, we supported the creation of a continuously learning 
organization. This will enable us to keep on introducing new 
improvements to our COPDnet model.
Despite our positive expectations with regard to the 
added value of our care pathway, we acknowledge some 
challenges in its use. Care according to the COPDnet model 
starts at the moment a patient with COPD is referred from 
primary care (GP) to secondary care (pulmonologist) because 
of persistent burden of disease. Hence, proper working 
of the COPDnet model presupposes timely and adequate 
medical diagnosis and a correct determination of the bur-
den of disease by the GP. Under- or misdiagnosis of COPD 
and a wrong estimate of the burden of disease in primary 
care would result in absent, late, or improper referrals to 
secondary care and challenge the proper application of the 
COPDnet model. In addition, during the diagnostic workup 
of the pulmonologist, the medical diagnosis is verified and 
adjusted if indicated.
Our COPDnet model strongly relies on the reinforcement 
of self-management strategies and seeks to initiate behavioral 
change in patients.33,59 However, much is still unclear in this 
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domain and requires further development.60 Also, our model 
requires a change in attitude on the part of the health care 
professionals. The one-dimensional medical perspective is 
abandoned to make way for a multidimensional biopsychoso-
cial approach to patients, which is not an easy task for health 
care providers.61,62 Furthermore, our COPDnet model relies 
on an adequate interaction between health care professionals 
working in different settings within the health care system, 
which are primary, secondary, and tertiary care settings. This 
means that although communications can be easily digitally 
supported, in real life, communication appears to be not as 
easy as that.63–65
Finally, although our integrated disease management 
pathway has been established in a scientific manner and the 
content is in line with current insights, we acknowledge that 
the COPDnet model is complex. Significant investments may 
be needed to use the full model. These investments must 
focus on clear agreements on effective communications 
between health care professionals in order to facilitate the 
transfer of patients across the COPDnet model. In addition, 
education and training of health care professionals in the use 
of the different components will be required and are therefore 
integrated in the QMS. Further studies on the feasibility, 
health status benefits, and costs of the model will provide 
answers as to the added value of the COPDnet model.
Conclusion
A new integrated disease management pathway in patients 
with COPD, named COPDnet, has been designed according 
to current knowledge on important disease-specific aspects as 
well as on insights regarding effective care in patients with 
a chronic condition. The model provides the application of 
principles of a learning organization, through a continuous 
evaluation of the results. This in turn may lead to future 
adaptations of the model. Once the model is stable, it will 
be evaluated for its feasibility, health status benefits, and 
costs of care.
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